Are somatoform disorders 'mental disorders'? A contribution to the current debate

Current Opinion in Psychiatry

Volumn 20, Issue 2, 2007, Pages 143-146

  Rief, Winfried ^a   Isaac, Mohan ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Classification; Medically unexplained symptoms; Somatization; Somatoform disorders

Indexed keywords

CLINICAL FEATURE; COGNITION; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; MENTAL DISEASE; MENTAL PATIENT; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; REVIEW; SOMATOFORM DISORDER; SYMPTOMATOLOGY;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MENTAL DISORDERS; RISK FACTORS; SICK ROLE; SOMATOFORM DISORDERS;

EID: 33846819949     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3280346999     Document Type: Review

References (32)

1. American Psychiatric Association. Diagnostic and statistical manual for mental disorders DSM-IV. Washington, DC: APA Press; 1994.
2. WHO: The ICD-10 Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: WHO; 1992.
3. Mayou R, Sharpe M, Kirmayer LJ, et al. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry 2005; 162:847-855.
4. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15:357-376.
5. Rief W, Henningsen P, Hiller W. Classification of somatoform disorders. Am J Psychiatry 2006; 163:746-747.
6. Rief W, Martin A, Klaiberg A, Brähler E. Specific effects of depression, panic, and somatic symptoms on illness behavior. Psychosom Med 2005; 67:596-601.
7. Starcevic V. Somatoform Disorders and DSM-V: Conceptual and political issues in the debate. Psychosomatics 2006; 47:227-281.
8. Strassnig M, Stowell KR, First MB, Pincus HA. General medical and psychiatric perspectives on somatoform disorders: separated by an uncommon language. Curr Opin Psychiatry 2006; 19:194-200.
9. Looper KJ, Kirmayer LJ. Behavioral medicine approaches to somatoform disorders. J Consult Clin Psychol 2002; 70:810-827.
10. Barsky AJ, Orav J, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical morbidity. Arch Gen Psychiatry 2005; 62:903-910.
11. Rief W, Barsky AJ. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 2005; 30:996-1002.
12. Karp JF, Scott J, Houck P, et al. Pain predicts longer time to remission during treatment of recurrent depression. J Clin Psychiatry 2005; 66:591-597.
13. Hirschfeld RMA, Mallinckrodt C, Lee TC, Detke MJ. Time course for depression-symptom improvement during treatment with duloxetine. Depress Anxiety 2005; 00:170-177.
14. Escobar JI. Developing practical indexes of somatization for use in primary care. J Psychosom Res 1997; 42:323-328.
15. Kroenke K, Spitzer RL, deGruy FV, et al. Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry 1997; 54:352-358.
16. Rief W, Hiller W. Toward empirically based criteria for somatoform disorders. J Psychosom Res 1999; 46:507-518.
17. Lim S-L, Kim J-H. Cognitive processing of emotional information in depression, panic, and somatoform disorder. J Abnorm Psychol 2005; 114:50-61.
18. Rief W, Hiller W, Margraf J. Cognitive aspects in hypochondriasis and the somatization syndrome. J Abnorm Psychol 1998; 107:587-595.
19. Seminovicz DA, Davis KD. Cortical responses to pain in healthy individuals depends on pain catastrophizing. Pain 2006; 120:297-306.
20. Rief W, Heitmüller AM, Reisberg K, Rüddel H. Why reassurance fails in patients with unexplained symptoms - an experimental investigation of remembered probabilities. PLoS Med 2006; 3:e269.
21. Rief W, Broadbent E. Explaining medically unexplained symptoms: models and mechanisms. Clin Psychol Review (in press).
22. Rief W, Avorn J, Barsky AJ. Medication-attributed adverse effects in placebo groups. Implications for assessment of adverse effects. Arch Intern Med 2006; 166:155-160.
23. Lorenz J, Hauck M, Paur RC, et al. Cortical correlates of false expectations during pain intensity judgments-a possible manifestation of placebo/nocebo cognitions. Brain Behav Immun 2005; 19:283-295.
24. Barsky AJ. Amplification, somatization, and the somatoform disorders. Psychosomatics 1992; 33:28-34.
25. Fink P. Somatization-beyond symptom count. J Psychosom Res 1996; 40:7-10.
26. Jackson J, Fiddler M, Kapur N, et al. Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. J Psychosom Res 2006; 60:357-363.
27. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes - one or many? Lancet 1999; 354:936-939.
28. Dickinson WP, Dickinson LM, DeGruy FV, et al. The somatization in primary care study: A tale of three diagnoses. Gen Hosp Psychiatry 2003; 25:1-7.
29. Smith RC, Gardiner JC, Lyles JS, et al. Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms. Psychosom Med 2005; 67:123-129.
30. van Staden W. Conceptual issues in undifferentiated somatoform disorders and chronic fatigue syndrome. Curr Opin Psychiatry 2006; 19:613-618.
31. Fink P, Rosendal M, Olesen F. Classification of somatization and functional somatic symptoms in primary care. ANZ J Psychiatry 2005; 39:772-781.
32. Fink P, Toft T, Hansen MS, Ornbol E, Olesen F. Symptoms and syndromes of bodily distress. Psychosom Med (in press).